Pharmaceutical Business review

China Biologic names new CEO and CFO

Mr Stanley Wong has resigned as president and CEO of the company, effective as of June 1, 2008. Mr Wong’s resignation was due to personal reasons and was not due to any disagreement with the company on any matter relating to the company’s operations, policies or practices. He will continue to serve as a consultant to the company until the end of 2008 in order to ensure a smooth transition for the management.

At the same time, Mr Chao Ming Zhao has resigned from his position as CFO in order to take over Mr Wong’s role as president and CEO, and Mr Tristan Kuo, the company’s vice president-finance, has been appointed to as the company’s new CFO, effective June 1, 2008.

Mr Zhao, said: “We highly value Mr Wong’s contribution to our company in the past and his assistance in effecting a smooth transaction. We are also pleased that Mr Kuo has agreed to serve as the company’s CFO. We expect that his in-depth finance experience and his background in the US capital market will inform our operations and business strategies and make him a valuable member of our team.”